K233537: FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K233537 (FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System, cleared 2024-04-23 for Abbott Diabetes Care, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K233537
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK233537
Cleared Device Trade / Generic NameFreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System
FDA Applicant on FilingAbbott Diabetes Care, Inc.
FDA 3-Letter Product ClassificationProduct Code QBJ
FDA Substantial Equivalence Decision Date2024-04-23
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Abbott Laboratories across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at Abbott Diabetes Care, Inc., compare peer devices under FDA Product Code QBJ, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.